Maks Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-05-2024
- Paid Up Capital ₹ 0.46 M
as on 19-05-2024
- Company Age 26 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Maks Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.46 M, as per Ministry of Corporate Affairs (MCA) records.
Madhusudan Agarwal and Anju Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24232DL1998PTC093355
- Company No.
093355
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Maks Pharmaceuticals Private Limited offer?
Maks Pharmaceuticals Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Maks Pharmaceuticals?
Board Members(2)
Financial Performance and Corporate Structure Insights of Maks Pharmaceuticals.
Maks Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maks Pharmaceuticals?
In 2017, Maks Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maks Pharmaceuticals?
Unlock and access historical data on people associated with Maks Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jul 10, 2017, Maks Pharmaceuticals has raised a total of ₹ 0.36 M, with the most recent deal valued at ₹ 0.36 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
